Drugs / 18F-EF5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01774760 | Mar 2013 → Sep 2016 | head and neck squamous cell carcinoma | Turku University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-EF5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01774760 ↗ |
| Modality | Diagnostic / imaging agent | “as a PET tracer for imaging hypoxia” NCT01774760 ↗ |
| Route | Intravenous | “The patients receive intravenous injection of 250-350 MBq of \[18F\]EF5.” NCT01774760 ↗ |